十二届国际癌症大会上有关抗癌药物的实验研究论文为116篇,临床研究论文为167篇,合计为280多篇,另有一些有关的文章尚未统计在内,占整个大会论文的十分之一以上。从数量上看,可认为是这次大会的重点内容之一;从质量上看,内容还是比较充实的,有一些新的进展。现从以下几方面概述,供参考。 At the 12th International Conference on Cancer, there were 116 research papers on anticancer drugs, 167 clinical research papers, totaling more than 280 articles, and some related articles that were not yet included, accounting for a total of 10% of the conference papers. One or more. From the quantitative point of view, it can be considered as one of the key contents of the conference; from the perspective of quality, the content is still relatively substantial and there are some new developments. Overview from the following aspects for reference.